Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04726358
What this trial is testing

ProCaLung: Project on Cancer of the Lung

Who this might be right for
Locally Advanced Lung Carcinoma
Jules Bordet Institute 1,000
Testing effectiveness (Phase 2)Study completedNCT01395758
What this trial is testing

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 96
Testing effectiveness (Phase 2)Study completedNCT01222312
What this trial is testing

Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel

Who this might be right for
Non Small Cell Lung Cancer
Krankenhaus Nordwest 88
Large-scale testing (Phase 3)Study completedNCT00718315
What this trial is testing

Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 201
Large-scale testing (Phase 3)Active Not RecruitingNCT03706690
What this trial is testing

Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 407
Not applicableLooking for participantsNCT02354274
What this trial is testing

Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®

Who this might be right for
NSCLC
Olfred Hansen 330
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Testing effectiveness (Phase 2)Study completedNCT02087423
What this trial is testing

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 446
Testing effectiveness (Phase 2)Looking for participantsNCT05967689
What this trial is testing

Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Who this might be right for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc. 220
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06604351
What this trial is testing

Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 39
Not applicableUnknownNCT05486988
What this trial is testing

CtDNA as a Biomarker for Treatment in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Fuzhou General Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00589056
What this trial is testing

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 55
Early research (Phase 1)Study completedNCT03590054
What this trial is testing

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Stage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more
Rahul Aggarwal 35
Testing effectiveness (Phase 2)Study completedNCT00022646
What this trial is testing

Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 157
Testing effectiveness (Phase 2)Study completedNCT00094861
What this trial is testing

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
DysphagiaNon-Small Cell Lung CancerLung Cancer
Swedish Orphan Biovitrum 100
Testing effectiveness (Phase 2)UnknownNCT00083083
What this trial is testing

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
American College of Radiology Imaging Network 250
Large-scale testing (Phase 3)UnknownNCT03074864
What this trial is testing

Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC

Who this might be right for
Non-small Cell Lung CancerEpidermal Growth Factor Receptor
Guangdong Provincial People's Hospital 90
Large-scale testing (Phase 3)Looking for participantsNCT06617416
What this trial is testing

AK104 in Subjects With Unresectable Locally Advanced NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Akeso 560
Early research (Phase 1)Active Not RecruitingNCT03893955
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerAdvanced Solid TumorsTriple-Negative Breast Cancer (TNBC)+2 more
AbbVie 150
Next Page